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Abstract
Background:  Depression amongst adolescents is a costly societal problem. Little research
documents the effectiveness of public mental health services in mapping this problem. Further, it is
not clear whether usual care in such services can be improved via clinician training in a relevant
evidence based intervention. One such intervention, found to be effective and easily learned
amongst novice clinicians, is Interpersonal Psychotherapy (IPT). The study described in the current
paper has two main objectives. First, it aims to investigate the impact on clinical care of
implementing Interpersonal Psychotherapy for Adolescents for the treatment of adolescent
depression within a rural mental health service compared with Treatment as Usual (TAU). The
second objective is to record the process and challenges (i.e. feasibility, acceptability, sustainability)
associated with implementing and evaluating an evidence-based intervention within a community
service. This paper outlines the study rationale and design for this community based research trial.
Methods/design: The study involves a cluster randomisation trial to be conducted within a Child
and Adolescent Mental Health Service in rural Australia. All clinicians in the service will be invited
to participate. Participating clinicians will be randomised via block design at each of four sites to (a)
training and delivery of IPT, or (b) TAU. The primary measure of impact on care will be a clinically
significant change in depressive symptomatology, with secondary outcomes involving treatment
satisfaction and changes in other symptomatology. Participating adolescents with significant
depressive symptomatology, aged 12 to 18 years, will complete assessment measures at Weeks 0,
12 and 24 of treatment. They will also complete a depression inventory once a month during that
period. This study aims to recruit 60 adolescent participants and their parent/guardian/s. A power
analysis is not indicated as an intra-class correlation coefficient will be calculated and used to inform
sample size calculations for subsequent large-scale trials. Qualitative data regarding process
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implementation will be collected quarterly from focus groups with participating clinicians over 18
months, plus phone interviews with participating adolescents and parent/guardians at 12 weeks and
24 weeks of treatment. The focus group qualitative data will be analysed using a Fourth Generation
Evaluation methodology that includes a constant comparative cyclic analysis method.
Discussion: This study protocol will be informative for researchers and clinicians interested in
considering, designing and/or conducting cluster randomised trials within community practice such
as mental health services.
Trial Registration: Australian Clinical Trials Registry ACTRNO12607000324415
Background
The immediate and long-term individual, interpersonal
and societal costs of depression are substantial [1]. Up to
one in five people will have suffered the effects of major
depression before the age of 18 years [2]. Despite limited
research regarding depression amongst rural adolescents,
we know that rural young men are at particularly high risk
of suicide compared to their metropolitan peers [3].
Depression during adolescence typically complicates pro-
gression through the essential developmental tasks of that
time leading to secondary difficulties [4,5]. To address
such problems, effective and accessible treatment is
needed. When detected, however, treatment provided for
depression is often inconsistent with evidence-based
treatment guidelines [6]. Whether or not such treatment
discrepancy is problematic for adolescent outcomes
remains unclear.
Questions remain regarding the most effective commu-
nity treatment for adolescents with depression. Antide-
pressant medication continues to be associated with
controversy regarding its efficacy and safety in use with
adolescents [7]. Structured psychological interventions,
particularly Cognitive Behaviour Therapy (CBT) and
Interpersonal Psychotherapy (IPT), have demonstrated
efficacy for the treatment of adolescent depression [8,9].
These psychotherapies are also used as treatments along-
side medication, or in the maintenance of post depressive
episodes.
Efficacy studies, requiring strict treatment and control
conditions, typically exclude clients with complex clinical
presentations. In reality, adolescents with depression fre-
quently present with comorbid mental or substance-use
disorders [10]. Effectiveness trials are needed to investi-
gate the feasibility and value of implementing structured
psychological interventions in community practice.
The available evidence suggests IPT is an efficacious treat-
ment for depression [11] which can be easily learned by
Australian mental health professionals [12] and other
novice therapists [13,14]. IPT is based on the formulation
that relationships are inherently inter-related with emo-
tional wellbeing. The therapy aims to decrease depressive
symptomatology and improve the relational functioning
of clients. The treatment focuses on a key interpersonal
problem area identified for the individual (e.g. grief, inter-
personal role disputes, interpersonal role transitions). IPT
is manual-based and time-limited and can be adminis-
tered effectively with or without medication [15].
From a systematic review of IPT efficacy in the treatment
of depressive spectrum disorders between 1974 and 2002,
a meta-analysis of 13 studies found IPT superior in effi-
cacy to placebo for mean improvement in depressive
symptoms (weighted mean difference [WMD] = -3.57;
95% confidence interval [CI] -5.98, -1.16) and lower
short-term drop out rate (relative risk [RR] = 0.59; 95% CI
0.36, 0.99). IPT was similar in efficacy to medication and
did not increase when combined with medication. IPT
performed significantly better than CBT for mean differ-
ence improvement (WMD = -2.16; 95% CI -4.16, -0.15)
though not for total remission [16].
Interpersonal Psychotherapy for Adolescents (IPT-A) has
evolved from the adult version (IPT), making adaptations
for the developmental issues of adolescents. Amongst
adolescents with depression, IPT-A has been demon-
strated to be superior to Treatment as Usual (TAU) in an
effectiveness study of five school-based mental health
clinics in New York [17]. In a trial with Puerto Rican ado-
lescents, remission of depressive symptoms was achieved
by 82% of adolescents receiving IPT-A and 59% receiving
CBT. Compared to the waiting list control, those in an
IPT-A group showed increased self-esteem and social
adaptation [18]. IPT-A has also demonstrated effective-
ness in the treatment of moderate to severe depression in
adolescents by well-supervised novice IPT-A therapists
[13].
IPT appears a promising intervention to trial for the treat-
ment of adolescents with depression attending a rural
Child and Adolescent Mental Health Services (CAMHS).
CAMHS aims to treat adolescents presenting with severe,
usually comorbid, mental health difficulties. In rural areas
this is complicated by limited availability of mentalBMC Psychiatry 2007, 7:53 http://www.biomedcentral.com/1471-244X/7/53
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health specialists. IPT appears particularly valuable in this
context given its appeal to clinicians and easy delivery by
a broad range of mental health professionals. The TAU of
adolescent depression in CAMHS is, on contrast, poorly
defined and of unknown quality or effectiveness.
The current project explores the impact of implementing
IPT in a rural CAMHS and the feasibility of comparing IPT
and TAU in practice. Given that implementation and eval-
uation of interventions in health services is typically com-
plex, a qualitative process evaluation will be incorporated
to explore the contextual factors associated with the
implementation [19].
The objectives of the clinical research are:
1. to investigate the impact on clinical care of implement-
ing IPT for the treatment of adolescent depression within
a rural CAMHS compared with TAU.
2. to evaluate the issues associated with implementing a
cluster randomised clinical trial in CAMHS (i.e. feasibility,
acceptability, sustainability).
Methods/Design
Sample
The research is being conducted within the LRH CAMHS
in rural Victoria, Australia. The service provides care for
children and adolescents across 40,000 square kilometres
with a population of 236,000. All clinicians, employed
full- or part-time within the LRH CAMHS, other than the
principle investigator, are invited to participate. At the
time of writing this includes 18 clinicians based at four
sites. The clinicians comprise psychologists, social work-
ers, occupational therapists, mental health nurses and a
psychiatry registrar. The trial aims to include a minimum
of 60 adolescent clients of LRH CAMHS, aged 12 to 18
years inclusive, to be recruited over 12 months. The sam-
ple size was determined on the basis of logistic feasibility
and resource constraints. In addition, given the lack of
information about the likely size of the intra-class correla-
tion coefficient (ICC), one intention of this study is to
estimate this statistic to assist in sample size calculation
for a larger subsequent effectiveness trial [20].
Inclusion/Exclusion criteria
Adolescents are eligible to participate if (a) they meet the
clinical cut-off for significant depressive symptomatology
in the Reynold's Adolescent Depression Scale – 2nd Edi-
tion (RADS-2) (T ≥ 61) [21], or (b) receive a DSM-IV-TR
[22] or ICD-10 [23] diagnosis of a depressive disorder (i.e.
Major Depressive Disorder (MDD), Dysthymic Disorder,
Depressive Disorder NOS, or Adjustment Disorder with
Depressed Mood) as affirmed by the team psychiatrist,
and (c) have a Children's Global Assessment Scale
(CGAS) [22] of 65 or lower. Clients will need parental/
guardian consent to participate and the agreement of the
CAMHS consultant psychiatrist. Adolescents will not be
included if they are actively suicidal, have a life-threaten-
ing condition, psychosis or schizophrenia. Parents/guard-
ians are eligible to participate if their adolescent child is
participating and they have no exclusion criteria.
Design
Approval for the research has been given by the Latrobe
Regional Hospital (LRH) Human Research Ethics Com-
mittee (HREC) and the Monash University Standing
Committee on Ethics in Research Involving Humans
(SCERH).
Randomisation
A cluster randomisation design was chosen over simple
client randomisation to overcome the obstacles of rand-
omizing adolescents to treatment streams (i.e. to specific
clinicians). Randomisation of adolescents could not be
assured given limitations on the availability of specific cli-
nicians at any given time and site.
The clinical assignment allocation process involves block
randomisation of participating clinicians within each of
the four sites to either IPT training or TAU. Allocation of
clients to clinicians continues as per usual practice of
availability. Randomisation was conducted centrally.
Treatments
The IPT stream comprises 12 weekly manual-based ses-
sions with the adolescent. The TAU stream comprises
usual care for the client. This may involve, for example,
individual counseling, family work, liaison with schools
and other professions, psychopharmacology, etc. In both
streams the clinician will record monthly the treatment
strategies used, the frequency of sessions, any additions or
changes in medication, and any critical incidents which
have occurred.
Concurrent process evaluation
Implementation issues will be investigated qualitatively
using quarterly focus groups with clinicians and through
individual telephone interviews with adolescent partici-
pants and their parent/guardians after receiving 12 weeks
and 24 weeks of treatment. The telephone interviews with
participating adolescents and parent/guardians will fol-
low a semi-structured schedule to guide the interview. The
questions will explore the participant's views on the treat-
ment provided. Example questions include, 'How effec-
tive do you feel the treatment has been that you have
received at CAMHS?', 'What have been the most helpful
components of the treatment?' and 'What changes would
you recommend in the treatment you have received atBMC Psychiatry 2007, 7:53 http://www.biomedcentral.com/1471-244X/7/53
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CAMHS?' The interview will take approximately 20 min-
utes.
A preliminary action research project was conducted with
the LRH CAMHS clinicians to encourage clinician input
and engagement in the design of the project. This com-
prised focus groups conducted with clinicians between
three and five occasions during 2006. This process helped
to shape the research to the clinical environment, and the
clinical environment to research involvement.
Main outcome measures
Monitoring and outcome assessment will use reliable and
valid measures applied in similar research. These include
adolescent self-report, parent-report and clinician ratings:
1. Clinician-rated diagnostic status and clinical severity
a. Health of the National Outcome Scales (HoNOSCA)
[24]. This is a global measure of child and adolescent
mental health status. It is a standard CAMHS outcome
measure used to rate changes in CAMHS client behaviour,
impairment, symptoms, and social functioning.
b. CGAS [22]. The CGAS, presented in the DSM-IV-TR, is
a clinician-rating scale (1 through 100) used rate the gen-
eral functioning of children and adolescents.
c. Treatment Recording Sheet (TRS). This clinician-report
record was adapted with CAMHS clinician input from the
Hawaii Child and Adolescent Mental Health Division
(CAMHD) Intervention Strategies Codesheet and Code-
book [25]. It is a monthly record of specific intervention
strategies used with an adolescent. It also records any crit-
ical incidents or medication changes occurring for the
adolescent during that month. Its development is dis-
cussed elsewhere.
2. Self-report
a. RADS-2 [21]. This adolescent-report measure takes 5 to
10 minutes for an adolescent to complete and has a Grade
3 reading level. It is a screening measure for adolescent
depression, providing a clinical cut-off for ratings of mild,
moderate and severe depressive symptomatology as well
as six critical items for clinical consideration. It shows
good reliability and validity.
b. Strengths and Difficulties Questionnaire (SDQ-S) [26].
The SDQ-S is a standard outcome measure administered
in CAMHS. It is a brief behavioural screening question-
naire for children and adolescents. It includes items
related to emotional, conduct, and hyperactivity/inatten-
tion symptoms, peer problems and prosocial behaviour.
c. Multidimensional Adolescent Satisfaction Scale (MASS)
[27]. The MASS is a 21-item scale measuring adolescents
satisfaction with various dimensions of mental health
service treatment. It has good reliability and demon-
strated convergent, discriminate, and predictive validity.
Its subscales include counselor qualities (perceived com-
petence of the clinician and quality of the relationship),
meeting needs (perceived adequacy of quantity and type
of service received), effectiveness (perceived benefit of
service), and counselor conflict (experience of negative
interactions with counselor).
d. Client Satisfaction Questionnaire (CSQ-8) [28]. The 8-
item CSQ-8 consists assesses overall level of satisfaction
with the treatment received.
3. Parent-report
a. Strengths and Difficulties Questionnaire (SDQ-P) [26].
The SDQ-P is the parent-version of the SDQ, as described
above
b. Short Mood and Feelings Questionnaire – Parent Ver-
sion (SMFQ-P) [29]. The SMFQ-P is a 5 minute 13-item
uni-dimensional parent-report measure of their child/
adolescent's depressive symptomatology. It shows good
internal reliability and discriminated between psychiatri-
cally referred and non-referred children.
c. Client Satisfaction Questionnaire (CSQ-8) [28]. This
measure is described above.
4. Other
Demographic details of clients. Age, gender, previous
mental health treatment, medication, parental occupa-
tion, family members in home, and ethnicity were
recorded.
5. Process evaluation
Evaluation questionnaires will be administered to all cli-
nicians regarding use of the TRS at onset of research
involvement and after 18 months. Evaluation of the IPT
training will be conducted with IPT-trained clinicians
immediately pre- and post-training and at 18 months fol-
low-up. Focus groups conducted quarterly with clinicians
will explore (a) contextual information regarding the
research implementation (to assist interpretation of the
quantitative trial results [19]), and (b) the feasibility,
acceptability and sustainability of conducting the clinical
research in CAMHS. Individual telephone interviews with
adolescent participants and their parent/guardians will
explore their satisfaction with treatment. Responses will
be audio-tape recorded and transcribed.
Analysis of results
Quantitative analysis
Analysis will adopt an intention-to-treat design. The pri-
mary quantitative outcome measure will be change inBMC Psychiatry 2007, 7:53 http://www.biomedcentral.com/1471-244X/7/53
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depressive symptomatology. This will be evaluated as (a)
the proportion of clients per treatment group with remis-
sion of depressive symptoms, defined as RADS-2 score
below the clinical cut-off; (b) the proportion of clients per
treatment group with clinical improvement of depressive
symptoms, defined as having a 50% or higher reduction
of depressive symptoms; (c) the difference in mean
depressive symptoms post-treatment. The secondary
quantitative outcome measure will be group differences in
adolescent and parent/guardian satisfaction with treat-
ment at 12 weeks and 24 weeks after start of treatment.
Treatment acceptability will also be measured by propor-
tion of clients per treatment group who do not complete
treatment [16].
The quantitative analyses will compare group differences
(i.e. remission, clinical improvement, mean difference,
and non-completion) between the IPT and TAU groups.
These analyses will allow estimation of the effect size of
IPT on these outcomes. Comparison will be made
between baseline and outcomes at 12 weeks and 24 weeks
from start of treatment. Our main aim is one of estimation
rather than hypothesis testing. Thus, effect sizes with 95%
confidence intervals will be calculated in favour of signif-
icance testing in order to provide information for subse-
quent trials.
Qualitative analysis
The qualitative data will be analysed using a Fourth Gen-
eration Evaluation methodology [30] that includes a con-
stant comparative cyclic analysis method. This involves
initial scanning of the data sets, development of themes
from the data sets, comparison of analysed data across the
data sets and formulation of final recommendations for
the improvements in similar CAMHS research trials.
Discussion
This protocol is the result of collaboration between a rural
CAMHS and Monash University. It developed from an
interest within CAMHS of implementing and evaluating a
focused evidence-based practice clinic. The key interests of
CAMHS and academic collaborators are on the evaluation
of practice and recording the process issues associated
with implementation of a clinical trial in CAMHS. The
study aims to inform development of a larger scale defin-
itive clinical trial.
The challenges of linking research and practice in health
services are well documented. With the increased pressure
on services to deliver and document evidence-based prac-
tice, the issues concerning integration of evidence and
practice are increasingly important. This study seeks to
look at these process issues arising in a rural CAMHS
embarking on a clinical trial.
A key aim of the project trial is to assess the feasibility of
conducting effectiveness trials of short-term psychological
interventions in a rural CAMHS. To assess issues of feasi-
bility and to aid interpretation of trial results, a combina-
tion of qualitative and quantitative methodologies will be
applied. The facilitated discussion groups with clinicians,
and interviews with adolescent and parent/guardian par-
ticipants, plus a research diary, aim to capture the process
issues as they arise and any related complexities and solu-
tions uncovered during the trial. These findings are con-
sidered important to assist further mental health services
researchers in the design of similar future ventures. They
are also important in a political environment of increas-
ing evidence-based practice pressure. Documentation of
the implementation obstacles and facilitators can practi-
cally inform discussions, expectations and decisions in
this area.
To fit in with the CAMHS realities, a cluster randomisa-
tion design was chosen over client randomisation. The
consideration of client randomisation raised concerns for
both clinicians and researchers. It was not feasible to do
client randomisation given the scarcity of clinicians based
at each of the four rural sites. At any given time a clinician
from the allocated treatment stream may not be available
at that site to work with the adolescent. For example, one
site may have only one participating clinician and others
only one for each treatment stream. Cluster randomisa-
tion provided the solution to this dilemma. It has the
advantage of allowing usual-care allocation of clients and
would provide an estimate of the ICC which would assist
sample size planning in a larger-scale subsequent trial, if
judged to be feasible and valuable.
Given the uncertainties existing regarding the safety and
efficacy of psychopharmacological treatment of adoles-
cents [7], it is important that effective psychological inter-
ventions are readily available for the treatment of
adolescent depression. IPT appears a useful intervention
for this purpose, given that it is described as easily learned
and applied by a range of mental health professionals
[13,14].
The study of TAU, however, is also an important compo-
nent of the study. First, there has been little study of what
TAU specifically entails in a multidisciplinary rural mental
health service. Clarification of the content of this is impor-
tant if we are to understand or evaluate it or compare it to
alternative forms of treatment. Second, the effectiveness
of TAU is unknown. If TAU proves as effective in practice
as identified evidence-based practices then questions
about the value of implementation efforts regarding the
latter may be raised. Definitive answers about effective-
ness of TAU compared to IPT in practice will, however,
require large sample sizes and replication of results withBMC Psychiatry 2007, 7:53 http://www.biomedcentral.com/1471-244X/7/53
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different studies, a challenging endeavor within commu-
nity practice.
The real-world context of this study means that it faces
important limitations. First, key variables cannot be con-
trolled in this environment. The methodology is impacted
by such factors as clinician turn-over, mixed attitudes to
involvement in research, questions of treatment fidelity,
challenges of data collection, amongst others. The deci-
sion was made, therefore, to describe the variables rather
than attempt to control.
A cluster randomisation design was utilized to avoid the
inevitable implementation failures that would occur ran-
domising individual participants to particular treatment
streams. Randomisation of individuals would not be pos-
sible when, for example, the relevant clinician at that site
was unavailable to take another case. Instead it was
decided that cases would be allocated by the team. This
lack of allocation blinding and randomisation of partici-
pants is likely to introduce bias to the allocation of cases.
Nevertheless, the cluster randomisation design is likely to
detect and account for the variability between groups. The
limitations found during this research will have important
findings. They will illustrate sources of complexity in seek-
ing to marry evidence and practice in child and mental
health services.
The transferability of efficacious treatments into practice
is an important issue for clinical researchers and clini-
cians. It is a complex area of implementation challenges.
This article describes the methodological responses to
challenges foreseen in conducting a clinical feasibility trial
concurrently being conducted within a rural CAMHS. This
study protocol illustrates a collaborative clinical research
design of potential value to researchers interested in inno-
vative and realistic treatment trials in this area.
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